| Modulation of amyloid β-protein clearance and Alzheimer’s disease susceptibility by the LDL receptor–related protein pathway DE Kang, CU Pietrzik, L Baum, N Chevallier, DE Merriam, MZ Kounnas, ... The Journal of clinical investigation 106 (9), 1159-1166, 2000 | 533 | 2000 |
| Biologic augmentation of rotator cuff repair with mesenchymal stem cells during arthroscopy improves healing and prevents further tears: a case-controlled study P Hernigou, CH Flouzat Lachaniette, J Delambre, S Zilber, P Duffiet, ... International orthopaedics 38, 1811-1818, 2014 | 462 | 2014 |
| Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664 V Galvan, OF Gorostiza, S Banwait, M Ataie, AV Logvinova, S Sitaraman, ... Proceedings of the National Academy of Sciences 103 (18), 7130-7135, 2006 | 302 | 2006 |
| Amyloid-β peptides interact with plasma proteins and erythrocytes: implications for their quantitation in plasma YM Kuo, TA Kokjohn, W Kalback, D Luehrs, DR Galasko, N Chevallier, ... Biochemical and biophysical research communications 268 (3), 750-756, 2000 | 274 | 2000 |
| Osteoblastic differentiation of human mesenchymal stem cells with platelet lysate N Chevallier, F Anagnostou, S Zilber, G Bodivit, S Maurin, A Barrault, ... Biomaterials 31 (2), 270-278, 2010 | 268 | 2010 |
| Presenilin 1 negatively regulates β-catenin/T cell factor/lymphoid enhancer factor-1 signaling independently of β-amyloid precursor protein and notch processing S Soriano, DE Kang, M Fu, R Pestell, N Chevallier, H Zheng, EH Koo The Journal of cell biology 152 (4), 785-794, 2001 | 268 | 2001 |
| Benefits of small volume and small syringe for bone marrow aspirations of mesenchymal stem cells P Hernigou, Y Homma, CH Flouzat Lachaniette, A Poignard, J Allain, ... International orthopaedics 37, 2279-2287, 2013 | 258 | 2013 |
| Platelets facilitate the wound-healing capability of mesenchymal stem cells by mitochondrial transfer and metabolic reprogramming J Levoux, A Prola, P Lafuste, M Gervais, N Chevallier, Z Koumaiha, K Kefi, ... Cell metabolism 33 (2), 283-299. e9, 2021 | 195 | 2021 |
| Characterization of New Polyclonal Antibodies Specific for 40 and 42 Amino Acid-Long Amyloid β Peptides: Their Use to Examine the Cell Biology of Presenilins … H Barelli, A Lebeau, J Vizzavona, P Delaere, N Chevallier, C Drouot, ... Molecular Medicine 3, 695-707, 1997 | 175 | 1997 |
| Stem cell therapy for the treatment of hip osteonecrosis: a 30-year review of progress P Hernigou, M Trousselier, F Roubineau, C Bouthors, N Chevallier, ... Clinics in orthopedic surgery 8 (1), 1-8, 2016 | 169 | 2016 |
| Growth Suppression by Acute PromyelocyticLeukemia-Associated Protein PLZF Is Mediated by Repression of c-myc Expression MJ McConnell, N Chevallier, W Berkofsky-Fessler, JM Giltnane, ... Molecular and Cellular Biology 23 (24), 9375-9388, 2003 | 155 | 2003 |
| Time-course and regional analyses of the physiopathological changes induced after cerebral injection of an amyloid β fragment in rats C Zussy, A Brureau, B Delair, S Marchal, E Keller, G Ixart, G Naert, ... The American journal of pathology 179 (1), 315-334, 2011 | 154 | 2011 |
| Osteonecrosis repair with bone marrow cell therapies: state of the clinical art P Hernigou, CH Flouzat-Lachaniette, J Delambre, A Poignard, J Allain, ... Bone 70, 102-109, 2015 | 145 | 2015 |
| Role of the proteasome in Alzheimer’s disease F Checler, CA Da Costa, K Ancolio, N Chevallier, E Lopez-Perez, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1502 (1), 133-138, 2000 | 132 | 2000 |
| Survival response to B-cell receptor ligation is restricted to progressive chronic lymphocytic leukemia cells irrespective of Zap70 expression PA Deglesne, N Chevallier, R Letestu, F Baran-Marszak, T Beitar, ... Cancer research 66 (14), 7158-7166, 2006 | 127 | 2006 |
| Cell therapy versus simultaneous contralateral decompression in symptomatic corticosteroid osteonecrosis: a thirty year follow-up prospective randomized study of one hundred … P Hernigou, A Dubory, Y Homma, I Guissou, CH Flouzat Lachaniette, ... International orthopaedics 42, 1639-1649, 2018 | 126 | 2018 |
| Feasibility and safety of treating non-unions in tibia, femur and humerus with autologous, expanded, bone marrow-derived mesenchymal stromal cells associated with biphasic … E Gómez-Barrena, P Rosset, F Gebhard, P Hernigou, N Baldini, H Rouard, ... Biomaterials 196, 100-108, 2019 | 122 | 2019 |
| Fluvoxamine alleviates ER stress via induction of Sigma-1 receptor T Omi, H Tanimukai, D Kanayama, Y Sakagami, S Tagami, M Okochi, ... Cell death & disease 5 (7), e1332-e1332, 2014 | 117 | 2014 |
| Cathepsin D displays in vitro β-secretase-like specificity N Chevallier, J Vizzavona, P Marambaud, CP Baur, M Spillantini, ... Brain research 750 (1-2), 11-19, 1997 | 113 | 1997 |
| Cancer risk is not increased in patients treated for orthopaedic diseases with autologous bone marrow cell concentrate P Hernigou, Y Homma, CH Flouzat-Lachaniette, A Poignard, N Chevallier, ... JBJS 95 (24), 2215-2221, 2013 | 111 | 2013 |
